The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.
For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty.
In this video, from the ALK/ROS1 breakout session, Drs. Jessica Lin and Chul Kim discuss what is known about bypass mechanisms (PIK3, MEK, ERK, etc).
A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech
For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.